$1.60
-0.23-12.57%
Benzinga
Benzinga
Benzinga
水曜日, 10 14
Benzinga
© 2026 Benzinga | All Rights Reserved
Tenax Therapeutics (TENX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.40 | $-0.75 | $-1.21 |
| Actual | $-0.35 | $-0.35 | $-0.38 | $-0.40 |
| Surprise | +5.41% | +12.5% | +49.3% | +66.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | — | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.38 | $-0.37 | $-0.37 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Jul 31, 2026 | $-0.35 | $-0.37 | 5.41 % |
| Q1 | May 12, 2026 | $-0.35 | $-0.40 | 12.5 % |
| Q4 | Mar 10, 2026 | $-0.38 | $-0.75 | 49.3 % |
| Q3 | Nov 12, 2025 | $-0.40 | $-1.21 | 66.9 % |